Aethlon Medical, Inc. (AEMD) vs Evogene Ltd. (EVGN)

A side-by-side comparison of Aethlon Medical, Inc. and Evogene Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AEMD vs EVGN

growth of $100 · dividends reinvested · last 10y
AEMD -100.0% (-65.8%/yr)EVGN -99.4% (-39.7%/yr)EVGN compounded faster over this window
Log scale — wide-divergence pair
00001101001kStart $10020182020202220242026$0$1
AEMD EVGN

AEMD vs EVGN: by the numbers

  • •EVGN is the larger company ($3M vs $3M market cap).
  • •Both run net losses; AEMD's is the smaller (0.00% vs -694.19% net margin).

Metrics side by side

Valuation

MetricAEMDEVGN
P/S ratioN/A2.60
P/B ratio0.64N/A

Profitability

MetricAEMDEVGN
Gross margin0.00%-6.25%
Operating margin0.00%-364.24%
Net margin0.00%-694.19%
ROE-133.43%N/A
ROIC-133.29%-130.12%

Growth (annualized)

MetricAEMDEVGN
Revenue CAGR (5Y)N/A2.86%
Total return CAGR (5Y)-78.27%-56.46%

Frequently asked

How have AEMD and EVGN total returns compared?
Over the past 10 years, AEMD delivered -65.74% and EVGN delivered -39.70% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.